These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38748286)

  • 141. System L amino acid transporter LAT1 accumulates O-(2-fluoroethyl)-L-tyrosine (FET).
    Habermeier A; Graf J; Sandhöfer BF; Boissel JP; Roesch F; Closs EI
    Amino Acids; 2015 Feb; 47(2):335-44. PubMed ID: 25385314
    [TBL] [Abstract][Full Text] [Related]  

  • 142. Correlation between positron emission tomography findings and glucose transporter 1, 3 and L-type amino acid transporter 1 mRNA expression in primary central nervous system lymphomas.
    Takahashi Y; Akahane T; Yamamoto D; Nakamura H; Sawa H; Nitta K; Ide W; Hashimoto I; Kamada H
    Mol Clin Oncol; 2014 Jul; 2(4):525-529. PubMed ID: 24940488
    [TBL] [Abstract][Full Text] [Related]  

  • 143. Comparative evaluation of transport mechanisms of trans-1-amino-3-[¹⁸F]fluorocyclobutanecarboxylic acid and L-[methyl-¹¹C]methionine in human glioma cell lines.
    Ono M; Oka S; Okudaira H; Schuster DM; Goodman MM; Kawai K; Shirakami Y
    Brain Res; 2013 Oct; 1535():24-37. PubMed ID: 23994214
    [TBL] [Abstract][Full Text] [Related]  

  • 144. Earlier diagnosis of progressive disease during bevacizumab treatment using O-(2-18F-fluorethyl)-L-tyrosine positron emission tomography in comparison with magnetic resonance imaging.
    Galldiks N; Rapp M; Stoffels G; Dunkl V; Sabel M; Langen KJ
    Mol Imaging; 2013; 12(5):273-6. PubMed ID: 23759368
    [TBL] [Abstract][Full Text] [Related]  

  • 145. Kinetic analyses of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid transport in Xenopus laevis oocytes expressing human ASCT2 and SNAT2.
    Okudaira H; Nakanishi T; Oka S; Kobayashi M; Tamagami H; Schuster DM; Goodman MM; Shirakami Y; Tamai I; Kawai K
    Nucl Med Biol; 2013 Jul; 40(5):670-5. PubMed ID: 23647854
    [TBL] [Abstract][Full Text] [Related]  

  • 146. (11)C-methionine PET/CT and MRI of primary central nervous system diffuse large B-cell lymphoma before and after high-dose methotrexate.
    Jang SJ; Lee KH; Lee JY; Choi JY; Kim BT; Kim SJ; Kim WS
    Clin Nucl Med; 2012 Oct; 37(10):e241-4. PubMed ID: 22955084
    [TBL] [Abstract][Full Text] [Related]  

  • 147. Differentiation of newly diagnosed glioblastoma multiforme and intracranial diffuse large B-cell Lymphoma using (11)C-methionine and (18)F-FDG PET.
    Okada Y; Nihashi T; Fujii M; Kato K; Okochi Y; Ando Y; Yamashita M; Maesawa S; Takebayashi S; Wakabayashi T; Naganawa S
    Clin Nucl Med; 2012 Sep; 37(9):843-9. PubMed ID: 22889772
    [TBL] [Abstract][Full Text] [Related]  

  • 148. Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis.
    Galldiks N; Stoffels G; Filss CP; Piroth MD; Sabel M; Ruge MI; Herzog H; Shah NJ; Fink GR; Coenen HH; Langen KJ
    J Nucl Med; 2012 Sep; 53(9):1367-74. PubMed ID: 22872742
    [TBL] [Abstract][Full Text] [Related]  

  • 149. The energetics of CNS white matter.
    Harris JJ; Attwell D
    J Neurosci; 2012 Jan; 32(1):356-71. PubMed ID: 22219296
    [TBL] [Abstract][Full Text] [Related]  

  • 150. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma.
    Villano JL; Koshy M; Shaikh H; Dolecek TA; McCarthy BJ
    Br J Cancer; 2011 Oct; 105(9):1414-8. PubMed ID: 21915121
    [TBL] [Abstract][Full Text] [Related]  

  • 151. Imaging of primary central nervous system lymphoma.
    Tang YZ; Booth TC; Bhogal P; Malhotra A; Wilhelm T
    Clin Radiol; 2011 Aug; 66(8):768-77. PubMed ID: 21513925
    [TBL] [Abstract][Full Text] [Related]  

  • 152. Comparison of 11C-methionine PET and 18F-FDG PET in patients with primary central nervous system lymphoma.
    Kawase Y; Yamamoto Y; Kameyama R; Kawai N; Kudomi N; Nishiyama Y
    Mol Imaging Biol; 2011 Dec; 13(6):1284-9. PubMed ID: 21042866
    [TBL] [Abstract][Full Text] [Related]  

  • 153. Use of PET in the diagnosis of primary CNS lymphoma in patients with atypical MR findings.
    Kawai N; Okubo S; Miyake K; Maeda Y; Yamamoto Y; Nishiyama Y; Tamiya T
    Ann Nucl Med; 2010 Jun; 24(5):335-43. PubMed ID: 20379859
    [TBL] [Abstract][Full Text] [Related]  

  • 154. FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading.
    Pöpperl G; Kreth FW; Mehrkens JH; Herms J; Seelos K; Koch W; Gildehaus FJ; Kretzschmar HA; Tonn JC; Tatsch K
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):1933-42. PubMed ID: 17763848
    [TBL] [Abstract][Full Text] [Related]  

  • 155. Usefulness of positron emission tomography in diagnosis and treatment follow-up of brain tumors.
    Schaller B
    Neurobiol Dis; 2004 Apr; 15(3):437-48. PubMed ID: 15056451
    [TBL] [Abstract][Full Text] [Related]  

  • 156. Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo.
    Heiss P; Mayer S; Herz M; Wester HJ; Schwaiger M; Senekowitsch-Schmidtke R
    J Nucl Med; 1999 Aug; 40(8):1367-73. PubMed ID: 10450690
    [TBL] [Abstract][Full Text] [Related]  

  • 157. Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors.
    Shoup TM; Olson J; Hoffman JM; Votaw J; Eshima D; Eshima L; Camp VM; Stabin M; Votaw D; Goodman MM
    J Nucl Med; 1999 Feb; 40(2):331-8. PubMed ID: 10025843
    [TBL] [Abstract][Full Text] [Related]  

  • 158. Methionine PET for follow-up of radiation therapy of primary lymphoma of the brain.
    Ogawa T; Kanno I; Hatazawa J; Inugami A; Fujita H; Shimosegawa E; Murakami M; Okudera T; Uemura K; Yasui N
    Radiographics; 1994 Jan; 14(1):101-10. PubMed ID: 8128041
    [TBL] [Abstract][Full Text] [Related]  

  • 159.
    Husby T; Johannessen K; Berntsen EM; Johansen H; Giskeødegård GF; Karlberg A; Fagerli UM; Eikenes L
    EJNMMI Rep; 2024 Jan; 8(1):2. PubMed ID: 38748286
    [TBL] [Abstract][Full Text] [Related]  

  • 160. 18F-FDG PET in the diagnosis and treatment of primary central nervous system lymphoma.
    Kawai N; Miyake K; Yamamoto Y; Nishiyama Y; Tamiya T
    Biomed Res Int; 2013; 2013():247152. PubMed ID: 23844359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.